Molecular and genetic characterization of the pOV plasmid from Pasteurella multocida and construction of an integration vector for Gallibacterium anatis

The pOV plasmid isolated from the Pasteurella multocida strain PMOV is a new plasmid, and its molecular characterization is important for determining its gene content and its replicative properties in Pasteurellaceae family bacteria. Antimicrobial resistance mediated by the pOV plasmid was tested in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Plasmid 2019-05, Vol.103, p.45-52
Hauptverfasser: López-Ochoa, Ana Jaqueline, Sánchez-Alonso, Patricia, Vázquez-Cruz, Candelario, Horta-Valerdi, Guillermo, Negrete-Abascal, Erasmo, Vaca-Pacheco, Sergio, Mejía, Ricardo, Pérez-Márquez, Manuel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 52
container_issue
container_start_page 45
container_title Plasmid
container_volume 103
creator López-Ochoa, Ana Jaqueline
Sánchez-Alonso, Patricia
Vázquez-Cruz, Candelario
Horta-Valerdi, Guillermo
Negrete-Abascal, Erasmo
Vaca-Pacheco, Sergio
Mejía, Ricardo
Pérez-Márquez, Manuel
description The pOV plasmid isolated from the Pasteurella multocida strain PMOV is a new plasmid, and its molecular characterization is important for determining its gene content and its replicative properties in Pasteurellaceae family bacteria. Antimicrobial resistance mediated by the pOV plasmid was tested in bacteria. Purified pOV plasmid DNA was used to transform E. coli DH5α and Gallibacterium anatis 12656-12, including the pBluescript II KS(−) plasmid DNA as a control for genetic transformation. The pOV plasmid was digested with EcoRI for cloning fragments into the pBluescript II KS(−) vector to obtain constructs and to determine the full DNA sequence of pOV. The pOV plasmid is 13.5 kb in size; confers sulfonamide, streptomycin and ampicillin resistance to P. multocida PMOV; and can transform E. coli DH5α and G. anatis 12656-12. The pOV plasmid was digested for the preparation of chimeric constructs and used to transform E. coli DH5α, conferring resistance to streptomycin (plasmid pSEP3), ampicillin (pSEP4) and sulfonamide (pSEP5) on the bacteria; however, similar to pBluescript II KS(−), the chimeric plasmids did not transform G. anatis 12656-12. A 1.4 kb fragment of the streptomycin cassette from pSEP3 was amplified by PCR and used to construct pSEP7, which in turn was used to interrupt a chromosomal DNA locus of G. anatis by double homologous recombination, introducing strA-strB into the G. anatis chromosome. The pOV plasmid is a wide-range, low-copy-number plasmid that is able to replicate in some gamma-proteobacteria. Part of this plasmid was integrated into the G. anatis 12656-12 chromosome. This construct may prove to be a useful tool for genetic studies of G. anatis. •The plasmid pOV can replicate independently from chromosomal DNA in several Pasteurellaceae bacterial species and in E. coli.•The plasmid belongs to IncX incompatibility group.•pOV sequence analysis revealed a novel integron arrangement.•A chimeric plasmid can to transform G. anatis and to recombine within the chromosome.
doi_str_mv 10.1016/j.plasmid.2019.04.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2216282791</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0147619X19300149</els_id><sourcerecordid>2216282791</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-2ec4998d84bd9a767bd88120e4942a24d9ceb05767e21239c5f9856902a562f33</originalsourceid><addsrcrecordid>eNqFkUFv1DAQhS0EokvhJ1D5yCVh7DjZ-FShqhSkonIAxM1y7EnrlRMvtrMS_BJ-Ll6y5crBmoO_N0_zHiGvGdQMWPd2V--9TpOzNQcmaxA1QPOEbBjItpK9hKdkA0xsq47J72fkRUo7AOg4656Ts4YB54KJDfn9KXg0i9eR6tnSe5wxO0PNg47aZIzul84uzDSMND8g3d99oydfOsYw0c86ZVwieq_ptPgcjLP67yoT5pTjYh7leqZuzngf14UHNDlEOpZ3o713w2q3TAUsRHpJno3aJ3x1mufk6_vrL1cfqtu7m49X724r03RtrjgaIWVvezFYqbfddrB9zzigkIJrLqw0OEBbPpAz3kjTjrJvOwlctx0fm-acvFn37mP4sWDKanLJHO-ZMSxJ8ZIY7_lWsoK2K2piSCniqPbRTTr-VAzUsRS1U6dw1LEUBUKVUoru4mSxDBPaf6rHFgpwuQJYDj04jCoZh7NB62KJSdng_mPxB1ajo28</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2216282791</pqid></control><display><type>article</type><title>Molecular and genetic characterization of the pOV plasmid from Pasteurella multocida and construction of an integration vector for Gallibacterium anatis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>López-Ochoa, Ana Jaqueline ; Sánchez-Alonso, Patricia ; Vázquez-Cruz, Candelario ; Horta-Valerdi, Guillermo ; Negrete-Abascal, Erasmo ; Vaca-Pacheco, Sergio ; Mejía, Ricardo ; Pérez-Márquez, Manuel</creator><creatorcontrib>López-Ochoa, Ana Jaqueline ; Sánchez-Alonso, Patricia ; Vázquez-Cruz, Candelario ; Horta-Valerdi, Guillermo ; Negrete-Abascal, Erasmo ; Vaca-Pacheco, Sergio ; Mejía, Ricardo ; Pérez-Márquez, Manuel</creatorcontrib><description>The pOV plasmid isolated from the Pasteurella multocida strain PMOV is a new plasmid, and its molecular characterization is important for determining its gene content and its replicative properties in Pasteurellaceae family bacteria. Antimicrobial resistance mediated by the pOV plasmid was tested in bacteria. Purified pOV plasmid DNA was used to transform E. coli DH5α and Gallibacterium anatis 12656-12, including the pBluescript II KS(−) plasmid DNA as a control for genetic transformation. The pOV plasmid was digested with EcoRI for cloning fragments into the pBluescript II KS(−) vector to obtain constructs and to determine the full DNA sequence of pOV. The pOV plasmid is 13.5 kb in size; confers sulfonamide, streptomycin and ampicillin resistance to P. multocida PMOV; and can transform E. coli DH5α and G. anatis 12656-12. The pOV plasmid was digested for the preparation of chimeric constructs and used to transform E. coli DH5α, conferring resistance to streptomycin (plasmid pSEP3), ampicillin (pSEP4) and sulfonamide (pSEP5) on the bacteria; however, similar to pBluescript II KS(−), the chimeric plasmids did not transform G. anatis 12656-12. A 1.4 kb fragment of the streptomycin cassette from pSEP3 was amplified by PCR and used to construct pSEP7, which in turn was used to interrupt a chromosomal DNA locus of G. anatis by double homologous recombination, introducing strA-strB into the G. anatis chromosome. The pOV plasmid is a wide-range, low-copy-number plasmid that is able to replicate in some gamma-proteobacteria. Part of this plasmid was integrated into the G. anatis 12656-12 chromosome. This construct may prove to be a useful tool for genetic studies of G. anatis. •The plasmid pOV can replicate independently from chromosomal DNA in several Pasteurellaceae bacterial species and in E. coli.•The plasmid belongs to IncX incompatibility group.•pOV sequence analysis revealed a novel integron arrangement.•A chimeric plasmid can to transform G. anatis and to recombine within the chromosome.</description><identifier>ISSN: 0147-619X</identifier><identifier>EISSN: 1095-9890</identifier><identifier>DOI: 10.1016/j.plasmid.2019.04.003</identifier><identifier>PMID: 31022414</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Ampicillin - pharmacology ; Anti-Bacterial Agents - pharmacology ; Base Pairing ; Base Sequence ; Chromosomes, Bacterial - chemistry ; Chromosomes, Bacterial - metabolism ; Deoxyribonuclease EcoRI - chemistry ; Drug Resistance, Bacterial - genetics ; Escherichia coli - drug effects ; Escherichia coli - genetics ; Escherichia coli - metabolism ; Gallibacterium anatis genomic interruption ; Gallibacterium anatis transformation ; Homologous Recombination ; Multidrug resistance ; Pasteurella multocida ; Pasteurella multocida - drug effects ; Pasteurella multocida - genetics ; Pasteurella multocida - metabolism ; Pasteurellaceae - drug effects ; Pasteurellaceae - genetics ; Pasteurellaceae - metabolism ; Plasmid characterization ; Plasmids - chemistry ; Plasmids - metabolism ; pOV plasmid ; Streptomycin - pharmacology ; Sulfonamides - pharmacology ; Transformation, Bacterial</subject><ispartof>Plasmid, 2019-05, Vol.103, p.45-52</ispartof><rights>2019 Elsevier Inc.</rights><rights>Copyright © 2019 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-2ec4998d84bd9a767bd88120e4942a24d9ceb05767e21239c5f9856902a562f33</citedby><cites>FETCH-LOGICAL-c365t-2ec4998d84bd9a767bd88120e4942a24d9ceb05767e21239c5f9856902a562f33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0147619X19300149$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31022414$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>López-Ochoa, Ana Jaqueline</creatorcontrib><creatorcontrib>Sánchez-Alonso, Patricia</creatorcontrib><creatorcontrib>Vázquez-Cruz, Candelario</creatorcontrib><creatorcontrib>Horta-Valerdi, Guillermo</creatorcontrib><creatorcontrib>Negrete-Abascal, Erasmo</creatorcontrib><creatorcontrib>Vaca-Pacheco, Sergio</creatorcontrib><creatorcontrib>Mejía, Ricardo</creatorcontrib><creatorcontrib>Pérez-Márquez, Manuel</creatorcontrib><title>Molecular and genetic characterization of the pOV plasmid from Pasteurella multocida and construction of an integration vector for Gallibacterium anatis</title><title>Plasmid</title><addtitle>Plasmid</addtitle><description>The pOV plasmid isolated from the Pasteurella multocida strain PMOV is a new plasmid, and its molecular characterization is important for determining its gene content and its replicative properties in Pasteurellaceae family bacteria. Antimicrobial resistance mediated by the pOV plasmid was tested in bacteria. Purified pOV plasmid DNA was used to transform E. coli DH5α and Gallibacterium anatis 12656-12, including the pBluescript II KS(−) plasmid DNA as a control for genetic transformation. The pOV plasmid was digested with EcoRI for cloning fragments into the pBluescript II KS(−) vector to obtain constructs and to determine the full DNA sequence of pOV. The pOV plasmid is 13.5 kb in size; confers sulfonamide, streptomycin and ampicillin resistance to P. multocida PMOV; and can transform E. coli DH5α and G. anatis 12656-12. The pOV plasmid was digested for the preparation of chimeric constructs and used to transform E. coli DH5α, conferring resistance to streptomycin (plasmid pSEP3), ampicillin (pSEP4) and sulfonamide (pSEP5) on the bacteria; however, similar to pBluescript II KS(−), the chimeric plasmids did not transform G. anatis 12656-12. A 1.4 kb fragment of the streptomycin cassette from pSEP3 was amplified by PCR and used to construct pSEP7, which in turn was used to interrupt a chromosomal DNA locus of G. anatis by double homologous recombination, introducing strA-strB into the G. anatis chromosome. The pOV plasmid is a wide-range, low-copy-number plasmid that is able to replicate in some gamma-proteobacteria. Part of this plasmid was integrated into the G. anatis 12656-12 chromosome. This construct may prove to be a useful tool for genetic studies of G. anatis. •The plasmid pOV can replicate independently from chromosomal DNA in several Pasteurellaceae bacterial species and in E. coli.•The plasmid belongs to IncX incompatibility group.•pOV sequence analysis revealed a novel integron arrangement.•A chimeric plasmid can to transform G. anatis and to recombine within the chromosome.</description><subject>Ampicillin - pharmacology</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Base Pairing</subject><subject>Base Sequence</subject><subject>Chromosomes, Bacterial - chemistry</subject><subject>Chromosomes, Bacterial - metabolism</subject><subject>Deoxyribonuclease EcoRI - chemistry</subject><subject>Drug Resistance, Bacterial - genetics</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli - metabolism</subject><subject>Gallibacterium anatis genomic interruption</subject><subject>Gallibacterium anatis transformation</subject><subject>Homologous Recombination</subject><subject>Multidrug resistance</subject><subject>Pasteurella multocida</subject><subject>Pasteurella multocida - drug effects</subject><subject>Pasteurella multocida - genetics</subject><subject>Pasteurella multocida - metabolism</subject><subject>Pasteurellaceae - drug effects</subject><subject>Pasteurellaceae - genetics</subject><subject>Pasteurellaceae - metabolism</subject><subject>Plasmid characterization</subject><subject>Plasmids - chemistry</subject><subject>Plasmids - metabolism</subject><subject>pOV plasmid</subject><subject>Streptomycin - pharmacology</subject><subject>Sulfonamides - pharmacology</subject><subject>Transformation, Bacterial</subject><issn>0147-619X</issn><issn>1095-9890</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUFv1DAQhS0EokvhJ1D5yCVh7DjZ-FShqhSkonIAxM1y7EnrlRMvtrMS_BJ-Ll6y5crBmoO_N0_zHiGvGdQMWPd2V--9TpOzNQcmaxA1QPOEbBjItpK9hKdkA0xsq47J72fkRUo7AOg4656Ts4YB54KJDfn9KXg0i9eR6tnSe5wxO0PNg47aZIzul84uzDSMND8g3d99oydfOsYw0c86ZVwieq_ptPgcjLP67yoT5pTjYh7leqZuzngf14UHNDlEOpZ3o713w2q3TAUsRHpJno3aJ3x1mufk6_vrL1cfqtu7m49X724r03RtrjgaIWVvezFYqbfddrB9zzigkIJrLqw0OEBbPpAz3kjTjrJvOwlctx0fm-acvFn37mP4sWDKanLJHO-ZMSxJ8ZIY7_lWsoK2K2piSCniqPbRTTr-VAzUsRS1U6dw1LEUBUKVUoru4mSxDBPaf6rHFgpwuQJYDj04jCoZh7NB62KJSdng_mPxB1ajo28</recordid><startdate>201905</startdate><enddate>201905</enddate><creator>López-Ochoa, Ana Jaqueline</creator><creator>Sánchez-Alonso, Patricia</creator><creator>Vázquez-Cruz, Candelario</creator><creator>Horta-Valerdi, Guillermo</creator><creator>Negrete-Abascal, Erasmo</creator><creator>Vaca-Pacheco, Sergio</creator><creator>Mejía, Ricardo</creator><creator>Pérez-Márquez, Manuel</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201905</creationdate><title>Molecular and genetic characterization of the pOV plasmid from Pasteurella multocida and construction of an integration vector for Gallibacterium anatis</title><author>López-Ochoa, Ana Jaqueline ; Sánchez-Alonso, Patricia ; Vázquez-Cruz, Candelario ; Horta-Valerdi, Guillermo ; Negrete-Abascal, Erasmo ; Vaca-Pacheco, Sergio ; Mejía, Ricardo ; Pérez-Márquez, Manuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-2ec4998d84bd9a767bd88120e4942a24d9ceb05767e21239c5f9856902a562f33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Ampicillin - pharmacology</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Base Pairing</topic><topic>Base Sequence</topic><topic>Chromosomes, Bacterial - chemistry</topic><topic>Chromosomes, Bacterial - metabolism</topic><topic>Deoxyribonuclease EcoRI - chemistry</topic><topic>Drug Resistance, Bacterial - genetics</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli - metabolism</topic><topic>Gallibacterium anatis genomic interruption</topic><topic>Gallibacterium anatis transformation</topic><topic>Homologous Recombination</topic><topic>Multidrug resistance</topic><topic>Pasteurella multocida</topic><topic>Pasteurella multocida - drug effects</topic><topic>Pasteurella multocida - genetics</topic><topic>Pasteurella multocida - metabolism</topic><topic>Pasteurellaceae - drug effects</topic><topic>Pasteurellaceae - genetics</topic><topic>Pasteurellaceae - metabolism</topic><topic>Plasmid characterization</topic><topic>Plasmids - chemistry</topic><topic>Plasmids - metabolism</topic><topic>pOV plasmid</topic><topic>Streptomycin - pharmacology</topic><topic>Sulfonamides - pharmacology</topic><topic>Transformation, Bacterial</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>López-Ochoa, Ana Jaqueline</creatorcontrib><creatorcontrib>Sánchez-Alonso, Patricia</creatorcontrib><creatorcontrib>Vázquez-Cruz, Candelario</creatorcontrib><creatorcontrib>Horta-Valerdi, Guillermo</creatorcontrib><creatorcontrib>Negrete-Abascal, Erasmo</creatorcontrib><creatorcontrib>Vaca-Pacheco, Sergio</creatorcontrib><creatorcontrib>Mejía, Ricardo</creatorcontrib><creatorcontrib>Pérez-Márquez, Manuel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Plasmid</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>López-Ochoa, Ana Jaqueline</au><au>Sánchez-Alonso, Patricia</au><au>Vázquez-Cruz, Candelario</au><au>Horta-Valerdi, Guillermo</au><au>Negrete-Abascal, Erasmo</au><au>Vaca-Pacheco, Sergio</au><au>Mejía, Ricardo</au><au>Pérez-Márquez, Manuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular and genetic characterization of the pOV plasmid from Pasteurella multocida and construction of an integration vector for Gallibacterium anatis</atitle><jtitle>Plasmid</jtitle><addtitle>Plasmid</addtitle><date>2019-05</date><risdate>2019</risdate><volume>103</volume><spage>45</spage><epage>52</epage><pages>45-52</pages><issn>0147-619X</issn><eissn>1095-9890</eissn><abstract>The pOV plasmid isolated from the Pasteurella multocida strain PMOV is a new plasmid, and its molecular characterization is important for determining its gene content and its replicative properties in Pasteurellaceae family bacteria. Antimicrobial resistance mediated by the pOV plasmid was tested in bacteria. Purified pOV plasmid DNA was used to transform E. coli DH5α and Gallibacterium anatis 12656-12, including the pBluescript II KS(−) plasmid DNA as a control for genetic transformation. The pOV plasmid was digested with EcoRI for cloning fragments into the pBluescript II KS(−) vector to obtain constructs and to determine the full DNA sequence of pOV. The pOV plasmid is 13.5 kb in size; confers sulfonamide, streptomycin and ampicillin resistance to P. multocida PMOV; and can transform E. coli DH5α and G. anatis 12656-12. The pOV plasmid was digested for the preparation of chimeric constructs and used to transform E. coli DH5α, conferring resistance to streptomycin (plasmid pSEP3), ampicillin (pSEP4) and sulfonamide (pSEP5) on the bacteria; however, similar to pBluescript II KS(−), the chimeric plasmids did not transform G. anatis 12656-12. A 1.4 kb fragment of the streptomycin cassette from pSEP3 was amplified by PCR and used to construct pSEP7, which in turn was used to interrupt a chromosomal DNA locus of G. anatis by double homologous recombination, introducing strA-strB into the G. anatis chromosome. The pOV plasmid is a wide-range, low-copy-number plasmid that is able to replicate in some gamma-proteobacteria. Part of this plasmid was integrated into the G. anatis 12656-12 chromosome. This construct may prove to be a useful tool for genetic studies of G. anatis. •The plasmid pOV can replicate independently from chromosomal DNA in several Pasteurellaceae bacterial species and in E. coli.•The plasmid belongs to IncX incompatibility group.•pOV sequence analysis revealed a novel integron arrangement.•A chimeric plasmid can to transform G. anatis and to recombine within the chromosome.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31022414</pmid><doi>10.1016/j.plasmid.2019.04.003</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0147-619X
ispartof Plasmid, 2019-05, Vol.103, p.45-52
issn 0147-619X
1095-9890
language eng
recordid cdi_proquest_miscellaneous_2216282791
source MEDLINE; Elsevier ScienceDirect Journals
subjects Ampicillin - pharmacology
Anti-Bacterial Agents - pharmacology
Base Pairing
Base Sequence
Chromosomes, Bacterial - chemistry
Chromosomes, Bacterial - metabolism
Deoxyribonuclease EcoRI - chemistry
Drug Resistance, Bacterial - genetics
Escherichia coli - drug effects
Escherichia coli - genetics
Escherichia coli - metabolism
Gallibacterium anatis genomic interruption
Gallibacterium anatis transformation
Homologous Recombination
Multidrug resistance
Pasteurella multocida
Pasteurella multocida - drug effects
Pasteurella multocida - genetics
Pasteurella multocida - metabolism
Pasteurellaceae - drug effects
Pasteurellaceae - genetics
Pasteurellaceae - metabolism
Plasmid characterization
Plasmids - chemistry
Plasmids - metabolism
pOV plasmid
Streptomycin - pharmacology
Sulfonamides - pharmacology
Transformation, Bacterial
title Molecular and genetic characterization of the pOV plasmid from Pasteurella multocida and construction of an integration vector for Gallibacterium anatis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T00%3A59%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20and%20genetic%20characterization%20of%20the%20pOV%20plasmid%20from%20Pasteurella%20multocida%20and%20construction%20of%20an%20integration%20vector%20for%20Gallibacterium%20anatis&rft.jtitle=Plasmid&rft.au=L%C3%B3pez-Ochoa,%20Ana%20Jaqueline&rft.date=2019-05&rft.volume=103&rft.spage=45&rft.epage=52&rft.pages=45-52&rft.issn=0147-619X&rft.eissn=1095-9890&rft_id=info:doi/10.1016/j.plasmid.2019.04.003&rft_dat=%3Cproquest_cross%3E2216282791%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2216282791&rft_id=info:pmid/31022414&rft_els_id=S0147619X19300149&rfr_iscdi=true